Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Volume:32 Issue:1 Number:4 ISSN#:2563-5476
RCT
ACE Report #13413
Ace Report Cover General Orthopaedics

Efficacy of High-Flow Nasal Cannula Oxygen Therapy for Patients with Severe COVID-19


How to Cite

OrthoEvidence. Efficacy of High-Flow Nasal Cannula Oxygen Therapy for Patients with Severe COVID-19. ACE Report. 2021;32(1):4. Available from: https://myorthoevidence.com/AceReport/Report/13413

Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

The value of high-flow nasal cannula oxygen therapy in treating novel coronavirus pneumonia

Eur J Clin Invest. 2020 Oct 31 : e13435.

Contributing Authors: XB Teng Y Shen MF Han G Yang L Zha JF Shi

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

Twenty-two patients hospitalized with severe COVID-19 were randomized to receive oxygen therapy using a high-flow nasal cannula oxygen system (n=22) or conventional oxygen therapy (n=10). Outcomes of interest included vitals (i.e., heart rate; respiratory rate; PaO2/FiO2 oxygenation index), infection indexes (C-reactive protein [CRP]; procalcitonin [PCT]; white blood cell count; lymphocyte count),...

To view the full report, start your 30-day free trial today

No credit card required

JOIN Forgot Password?

Not sure if you want to join OrthoEvidence?

Access this report without an Account.

Success, an email containing a link to access this report has been sent to your inbox.

CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.

LEARN MORE

Please Login or Join to leave comments.